Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

NCT01007448 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Cutaneous T-cell Lymphoma

Interventions

DRUG: Bexarotene

Sponsor

Bausch Health Americas, Inc.